CJC/IPA Protocol
Also known as: CJC-1295 no DAC with Ipamorelin, Mod GRF 1-29 with Ipamorelin
Primary recreational use: Muscle growth and recovery
What is CJC/IPA Protocol?
The CJC/IPA Protocol combines CJC-1295 without DAC (Mod GRF 1-29) and Ipamorelin to optimize growth hormone through a dual-pathway approach. Primarily used by fitness enthusiasts for growth hormone optimization, it is popular for muscle growth and recovery benefits. This combination is not FDA-approved, and users should be cautious of regulatory and contamination risks.
Primary Benefits
Enhances protein synthesis. Supports muscle recovery. Promotes lean mass preservation.
How It Works
CJC-1295 without DAC binds to GHRH receptors, stimulating GH synthesis via cAMP/PKA pathways. Ipamorelin acts on ghrelin receptors enhancing GH release without influencing cortisol levels. Together, they mimic natural pulsatile GH secretion, elevating GH levels synergistically.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T use if you have a history of cancer due to IGF-1 stimulation.
- 2.NEVER use higher doses without medical guidance, as it increases side effect risk.
- 3.AVOID using it continuously without breaks to prevent receptor desensitization.
- 4.DON'T inject within 2 hours of eating to prevent blunted GH response.
- 5.NEVER mix DAC and non-DAC versions of CJC-1295 together in the protocol.
- 6.DON'T skip rotating injection sites to prevent lipodystrophy.
- 7.DON'T exceed recommended dosing (300 mcg of each peptide) to minimize side effects.
- 8.AVOID using without medical supervision if you have diabetes or cardiovascular issues.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Muscle Growth and Recovery
moderate evidenceUsed by fitness enthusiasts to promote muscle gain and recovery due to increased growth hormone release.
Evidence: Various sources mention anecdotal and limited clinical evidence supporting muscle growth and recovery through enhanced GH release.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Before bed
Notes: Administer on an empty stomach for optimal results.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Enhanced GH pulsatility | 100-150 mcg each | Twice daily (AM and before bed) | Subcutaneous injection |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Potential insulin resistance
- Impact on tumor growth (IGF-1 related)
Injection-Specific Warnings
- Injection site reactions
- Proper sterile technique required
Storage
Harm Reduction Information
Quality Concerns
- Contamination from unregulated sources
- Purity variability in compounded products
- Issues with reconstitution clarity
Safety Tips
- Use only pharmaceutical-grade products with COA.
- Follow proper reconstitution methods with bacteriostatic water.
- Rotate injection sites consistently.
- Start with conservative dosing to assess tolerance.
Warning Signs to Stop
- Severe joint pain
- Persistent headaches
- Uncontrolled high blood sugar
- Signs of infection at injection site
Seek Medical Help Immediately If
- Severe allergic reactions
- Uncontrolled blood sugar levels
- Signs of tumor growth or significant swelling
Frequently Asked Questions
Common questions about CJC/IPA Protocol
How long until I see effects?
With the CJC/IPA Protocol, you may begin to see improvements in sleep within 1-2 weeks and enhanced recovery from exercise within 2-4 weeks.
What time of day should I take it?
It's best to use the CJC/IPA Protocol at night before bed, as it aligns with natural GH release during deep sleep.
How can I minimize side effects?
To minimize side effects with the CJC/IPA Protocol, start with a conservative dose, rotate injection sites, and ensure injections are at least 2-3 hours after a meal.
Does tolerance develop?
Yes, desensitization can occur with continuous use of the CJC/IPA Protocol. A 5-days-on, 2-days-off cycle is recommended to maintain sensitivity.
How should I store it?
Store reconstituted peptides for the CJC/IPA Protocol in the refrigerator at 2-8°C and use them within 30 days to ensure potency.
Do I need to cycle it?
Cycling the CJC/IPA Protocol is necessary. An 8-12 week cycle with a 4-week break helps maintain effectiveness and receptor response.
Reported Combinations
Compounds reported to be used alongside CJC/IPA Protocol in community discussions
MK-677
Enhances GH secretion over time.
BPC-157
Improves recovery and healing times.
AOD-9604
Assists in targeted fat reduction efforts.
Reported Interactions
Interactions reported in literature and community discussions.
Can affect blood sugar regulation.
May blunt growth hormone response.
May require dose adjustments.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
Not FDA-approved, prohibited by WADA
UK
Not FDA-approved
EU
Not FDA-approved
Australia
Not FDA-approved
Canada
Not FDA-approved
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 5, 2023